Who is sponsoring NCT07057648?

NCT07057648 is sponsored by Ulsan University Hospital.

What drugs are being tested in NCT07057648?

Interventions in NCT07057648: Shape-sensing Robotic-assisted Bronchoscopy (ssRAB).

What condition does NCT07057648 study?

NCT07057648 studies Lung Nodules, Peripheral Lung Lesions, Pulmonary Nodules, Lung Cancers, Bronchoscopy.

Is NCT07057648 still recruiting?

NCT07057648 is currently recruiting now. Last updated 13 February 2026.

Last reviewed 2026-02-13 · How we verify

NCT07057648: ULSAN-ION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea

Recruiting now Last updated 13 February 2026

What this trial tests

trial testing Shape-sensing Robotic-assisted Bronchoscopy (ssRAB) in Lung Nodules in 100 participants. Currently enrolling.

Timeline

9 July 2025

Primary endpoint
31 December 2026

31 May 2027

Quick facts

Lead sponsor	Ulsan University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	9 July 2025
Primary completion	31 December 2026
Estimated completion	31 May 2027
Sites	1 location across South Korea

Drugs / interventions tested

Shape-sensing Robotic-assisted Bronchoscopy (ssRAB)

Conditions studied

Lung Nodules — all drugs for Lung Nodules →
Peripheral Lung Lesions — all drugs for Peripheral Lung Lesions →
Pulmonary Nodules — all drugs for Pulmonary Nodules →
Lung Cancers — all drugs for Lung Cancers →

Sponsor

Ulsan University Hospital

Who can join

19 and older, any sex, with Lung Nodules or Peripheral Lung Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

What is this study about? This study tests a new robotic technology to take tissue samples from lung nodules (small spots in the lungs). Some lung nodules are cancer, but doctors need a tissue sample to know for sure. What is the problem? Current methods to get tissue from lung nodules only work about 7 out of 10 times. When they don't work, doctors may need riskier procedures. What is the new technology? The new technology is called robotic bronchoscopy (ssRAB). It uses a robot with special sensors to guide a thin tube more accurately to lung nodules than current methods. Who can join? Adults aged 19 or older who have lung nodules that need tissue sampling and are healthy enough for the procedure. What happens? Participants will have the robotic procedure while asleep under anesthesia. The robot guides a thin tube to the lung nodule to take a small tissue sample. Participants are watched for problems and followed for 6 months. What are the risks and benefits? The new technology may be more accurate and safer than current methods. The main risks are small chance of lung collapse or bleeding, similar to regular procedures. Why is this important? This study will show if the new robotic technology works well and is safe in Korea. If successful, it could help diagnose lung cancer earlier and more accurately. This study will include 100 people at Ulsan University Hospital in Korea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Nodules

Currently open trials in the same condition.

NCT07368829 — AI-Driven Autonomous Registration in Robotic Bronchoscopy · NA · recruiting
NCT06821451 — Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection · NA · recruiting
NCT07136961 — Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary · NA · active not recruiting
NCT06728319 — A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrat · active not recruiting
NCT07401797 — Specimens for Lung Cancer Panel Design · recruiting

Other Ulsan University Hospital trials

Trials by the same sponsor.

NCT07398001 — Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment · NA · not yet recruiting
NCT03270852 — Enhanced Reality for Hemiparetic Arm in the Stroke Patients · NA · unknown
NCT03789409 — Intermittent Fasting Following Acute Ischemic Stroke · NA · unknown
NCT03787524 — Prediction of Functional Health Status and Aspiration Using Multiple Dysphagia Scales Over 6 Months After Acute Stroke · unknown
NCT03779815 — Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07057648 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ulsan University Hospital
Last refreshed: 13 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07057648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing